title: The pattern and outcome of burn injuries at Wesley Guild Hospital, Ilesha, Nigeria: a review of 156 cases.
abstract: A review of 156 patients with burn injuries admitted over a 5-year period (January 1988-December 1992) at Wesley Guild Hospital, Ilesha, was undertaken. The male:female ratio was 1.6:1. About 70% of the cases were between 1 and 10 years of age (mean 9 years). Scalds were responsible for 50.6% of the cases while naked flames, including kerosene explosion and burns at road traffic accidents, were responsible for 43.5%. Seventy-one per cent were due to domestic accidents. The burns were categorized as major in 70% of cases. The trunk accounted for 56.4% of anatomical areas involved, upper limbs 51.3%, lower limbs 48%, while head and neck accounted for 28.8%. Open dressings were used in 70.5% of the cases, combined open and closed dressings in 22.4% and closed dressings in 10.3%. In about 90% of cases, silver sulphadiazine was used as a topical antimicrobial agent while natural honey was used on the rest. Wound infection was the commonest complication occurring in 24.4%, while mortality was recorded in 7.7% of cases.
authors.affiliation: Department of Surgery, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
authors.forename: K
authors.initials: K
authors.lastname: Adesunkanmi
authors.forename: O A
authors.initials: OA
authors.lastname: Oyelami
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001458:Bandages; D001830:Body Surface Area; D002056:Burns / Q000145:classification / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007223:Infant; D015601:Injury Severity Score; D008297:Male; D008875:Middle Aged; D009549:Nigeria / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D010343:Patient Admission / Q000639:trends*; D011159:Population Surveillance; D011379:Prognosis; D011446:Prospective Studies; D012189:Retrospective Studies; D012837:Silver Sulfadiazine / Q000627:therapeutic use; D016896:Treatment Outcome; D014946:Wound Infection / Q000453:epidemiology
chemical_list: D012837:Silver Sulfadiazine